Drug name - Lexapro
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US6916941 | ALLERGAN | Crystalline composition containing escitalopram |
Aug, 2022
(a month ago) | |
| CN1660074A | ALLERGAN | Crystalline Composition Containing Escitalopram |
Oct, 2007
(15 years ago) | |
| CN1311819C | ALLERGAN | Crystalline Composition Containing Escitalopram |
Jul, 2022
(2 months ago) | |
| CN1536997A | ALLERGAN | Crystalline Composition Containing Escitalopram |
Jul, 2022
(2 months ago) | |
| IN227935B | ALLERGAN | A Method For Manufacture Of Crystalline Particles Of Escitalpram Oxalate |
Jul, 2022
(2 months ago) | |
| IN200400405P4 | ALLERGAN | Crystalline Composition Containing Escitalopram |
Jul, 2022
(2 months ago) | |
| EP1522539A1 | ALLERGAN | Crystalline Composition Containing Escitalopram |
Sep, 2010
(12 years ago) | |
| EP1522539B1 | ALLERGAN | Crystalline Composition Containing Escitalopram |
Sep, 2010
(12 years ago) | |
| EP1414435B1 | ALLERGAN | Crystalline Composition Containing Escitalopram |
Jul, 2022
(2 months ago) | |
| EP1414435A1 | ALLERGAN | Crystalline Composition Containing Escitalopram |
Jul, 2022
(2 months ago) | |
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
|
US6916941
(Pediatric) | ALLERGAN | Crystalline composition containing escitalopram |
Feb, 2023
(4 months from now) | |
|
US7420069
(Pediatric) | ALLERGAN | Crystalline composition containing escitalopram |
Feb, 2023
(4 months from now) | |
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| EQ 5MG BASE | TABLET;ORAL | Prescription |
| EQ 10MG BASE | TABLET;ORAL | Prescription |
| EQ 20MG BASE | TABLET;ORAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.